Allspring Global Investments Holdings LLC Purchases 10,452 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)

Allspring Global Investments Holdings LLC boosted its position in Utah Medical Products, Inc. (NASDAQ:UTMD) by 838.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,698 shares of the medical instruments supplier’s stock after acquiring an additional 10,452 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.35% of Utah Medical Products worth $719,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Golden State Wealth Management LLC acquired a new position in shares of Utah Medical Products during the fourth quarter worth $31,000. R Squared Ltd acquired a new position in shares of Utah Medical Products during the fourth quarter worth $49,000. BNP Paribas Financial Markets increased its holdings in shares of Utah Medical Products by 102.7% during the third quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock worth $75,000 after buying an additional 566 shares in the last quarter. SG Americas Securities LLC acquired a new position in shares of Utah Medical Products during the fourth quarter worth $157,000. Finally, Virtu Financial LLC acquired a new position in shares of Utah Medical Products during the third quarter worth $207,000. 69.60% of the stock is owned by institutional investors.

Utah Medical Products Trading Down 0.9 %

Shares of UTMD opened at $60.20 on Monday. The stock has a market capitalization of $204.08 million, a P/E ratio of 15.24 and a beta of 0.08. The firm’s fifty day simple moving average is $61.42 and its two-hundred day simple moving average is $64.42. Utah Medical Products, Inc. has a 12 month low of $58.87 and a 12 month high of $77.33.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings data on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share (EPS) for the quarter. Utah Medical Products had a net margin of 33.92% and a return on equity of 11.07%.

Utah Medical Products Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 3rd. Shareholders of record on Friday, March 14th will be paid a $0.305 dividend. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.22 annualized dividend and a yield of 2.03%. Utah Medical Products’s dividend payout ratio (DPR) is 30.89%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded Utah Medical Products from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 7th.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.